Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp.
AUTOR(ES)
Law, D
RESUMO
The in vitro activity of Schering 56592, a new azole drug, was compared with those of fluconazole and itraconazole against 103 isolates of Candida comprising 10 different species. Schering 56592 was more active than itraconazole and fluconazole, and it was active against many fluconazole-resistant isolates.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=164118Documentos Relacionados
- In Vitro Activities of Posaconazole (Sch 56592) Compared with Those of Itraconazole and Fluconazole against 3,685 Clinical Isolates of Candida spp. and Cryptococcus neoformans
- Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae.
- In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp.
- In vitro activity of BMS-181184 compared with those of fluconazole and amphotericin B against various candida spp.
- In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.
